<--- Back to Details
First PageDocument Content
Kidney diseases / Organ failure / Renal physiology / ACE inhibitors / Endocrinology / Contrast-induced nephropathy / Chronic kidney disease / Angiotensin II receptor antagonist / Diabetic nephropathy / Anatomy / Medicine / Biology
Kidney diseases
Organ failure
Renal physiology
ACE inhibitors
Endocrinology
Contrast-induced nephropathy
Chronic kidney disease
Angiotensin II receptor antagonist
Diabetic nephropathy
Anatomy
Medicine
Biology

ACE-I/ARB Therapy prior to Contrast Exposure: What Should the Clinician Do?

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Download Document from Source Website

File Size: 576,05 KB

Share Document on Facebook

Similar Documents

PRODUCT MONOGRAPH  COZAAR® losartan potassium tablets 25, 50 and 100 mg Angiotensin II Receptor Antagonist

PRODUCT MONOGRAPH COZAAR® losartan potassium tablets 25, 50 and 100 mg Angiotensin II Receptor Antagonist

DocID: 1uB2r - View Document

Comments to the 2007 recommendations for the treatment of essential hypertension by the Swiss Society of Hypertension

Comments to the 2007 recommendations for the treatment of essential hypertension by the Swiss Society of Hypertension

DocID: 1r7aU - View Document

lisinopril pregnancy class. lisinopril dosis letal, lisinopril vs altace hydrochloroth lisinopril. negative side effects of lisinopril. lisinopril zinc and selenium lisinopril tablets wockhardt, dangerous side affects of

lisinopril pregnancy class. lisinopril dosis letal, lisinopril vs altace hydrochloroth lisinopril. negative side effects of lisinopril. lisinopril zinc and selenium lisinopril tablets wockhardt, dangerous side affects of

DocID: 1qMap - View Document

6213 Old Keene Mill Court ♦ Springfield, VAPhone:  ♦ www.PQAalliance.org ♦ Fax: CONTACT: Woody Eisenberg Sr. VP, Performance Measurement & Strategic Alliances

6213 Old Keene Mill Court ♦ Springfield, VAPhone: ♦ www.PQAalliance.org ♦ Fax: CONTACT: Woody Eisenberg Sr. VP, Performance Measurement & Strategic Alliances

DocID: 1qilE - View Document

GuidelinesGuidelines

GuidelinesGuidelines

DocID: 1oUt8 - View Document